Alphabet’s health and life sciences spinout Verily is strengthening its clinical research arm by acquiring the Raleigh, N.C.-based clinical trial management system developer SignalPath.
This marks Verily’s first major acquisition, the company shared in its announcement. It did not disclose the terms of the deal.
Founded in 2014, SignalPath has created a suite of software products designed to...
